Literature DB >> 26613525

Parkinson's Disease in the Gulf Countries: An Updated Review.

Yassar Alamri1, Michael MacAskill, Tim Anderson, Hani Benamer.   

Abstract

BACKGROUND: The Arabian Gulf region is a rapidly developing part of the world. With the increase in average life-expectancy, idiopathic Parkinson's disease (PD), is also expected to increase in prevalence. Furthermore, the high rate of consanguinity among Arabs probably makes familial cases of PD more likely to be encountered than other areas in the world. This review provides an update on the published literature on sporadic and familial PD in Gulf Arabs.
SUMMARY: Although the Arab population of this region shares religious beliefs and demographic characteristics with other Arabs, their environmental exposures and genetic makeup may be different. This could account for the relatively low prevalence of PD reported in the Al-Thugba study (27 per 100,000) compared with prevalence rates by most other studies on Arab (mainly North African) populations (31.4-557.4 per 100,000). KEY MESSAGES: Gulf countries are considered rich countries, which makes conducting nation-wide or even international studies logistically easier than it is in many other countries. Such multinational research can be organized by the existing Gulf Cooperation Council, or through a collaboration of the Ministries of Health. This would, hopefully, culminate in the introduction of more research centers, as well as the implementation of better health care policies and practices for the ageing community.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26613525     DOI: 10.1159/000442283

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  6 in total

1.  Effectiveness of Serious Games for Leap Motion on the Functionality of the Upper Limb in Parkinson's Disease: A Feasibility Study.

Authors:  Edwin Daniel Oña; Carlos Balaguer; Roberto Cano-de la Cuerda; Susana Collado-Vázquez; Alberto Jardón
Journal:  Comput Intell Neurosci       Date:  2018-04-11

2.  Public knowledge and awareness about Parkinson's disease in Saudi Arabia.

Authors:  Alwaleed M Alyamani; Jammaz Alarifi; Abdulmajeed Alfadhel; Fahad Alfarawi; Khalid Alshamardl; Faisal Alassaf; Mohammed Alyamani; Fahad Alshahrani
Journal:  J Family Med Prim Care       Date:  2018 Nov-Dec

3.  Leap motion controlled video game-based therapy for upper limb rehabilitation in patients with Parkinson's disease: a feasibility study.

Authors:  Pilar Fernández-González; María Carratalá-Tejada; Esther Monge-Pereira; Susana Collado-Vázquez; Patricia Sánchez-Herrera Baeza; Alicia Cuesta-Gómez; Edwin Daniel Oña-Simbaña; Alberto Jardón-Huete; Francisco Molina-Rueda; Carlos Balaguer-Bernaldo de Quirós; Juan Carlos Miangolarra-Page; Roberto Cano-de la Cuerda
Journal:  J Neuroeng Rehabil       Date:  2019-11-06       Impact factor: 4.262

4.  Parkinson's Disease in the Middle East, North Africa, and South Asia: Consensus from the International Parkinson and Movement Disorder Society Task Force for the Middle East.

Authors:  Hanan Khalil; Lana M Chahine; Junaid Siddiqui; Mehri Salari; Shaimaa El-Jaafary; Zakiyah Aldaajani; Mishal Abu Al-Melh; Tareq Mohammad Mohammad; Muneer Abu Snineh; Nadir A Syed; Mohit Bhatt; Mohammad Ahsan Habib; Majed Habahbeh; Samer D Tabbal; Beomseok Jeon; Jawad A Bajwa
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

5.  Evidence for prehistoric origins of the G2019S mutation in the North African Berber population.

Authors:  Rafiqua Ben El Haj; Ayyoub Salmi; Wafa Regragui; Ahmed Moussa; Naima Bouslam; Houyam Tibar; Ali Benomar; Mohamed Yahyaoui; Ahmed Bouhouche
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

6.  Validity of a Fully-Immersive VR-Based Version of the Box and Blocks Test for Upper Limb Function Assessment in Parkinson's Disease.

Authors:  Edwin Daniel Oña; Alberto Jardón; Alicia Cuesta-Gómez; Patricia Sánchez-Herrera-Baeza; Roberto Cano-de-la-Cuerda; Carlos Balaguer
Journal:  Sensors (Basel)       Date:  2020-05-13       Impact factor: 3.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.